Teva Pharmaceutical Fine Chemicals S.r.l., a subsidiary of Teva Pharmaceutical Industries Ltd., is a prominent player in the pharmaceutical fine chemicals sector. Headquartered in Italy, the company operates extensively across Europe and beyond, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in the early 20th century, Teva has achieved significant milestones, including advancements in sustainable production methods. Teva Pharmaceutical Fine Chemicals is renowned for its high-quality, cost-effective products that cater to a diverse range of therapeutic areas, including oncology and central nervous system disorders. The company’s commitment to innovation and regulatory compliance has solidified its position as a trusted partner in the pharmaceutical industry. With a strong focus on quality and sustainability, Teva continues to lead in the competitive landscape of pharmaceutical fine chemicals.
How does Teva Pharmaceutical Fine Chemicals S.r.l's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Teva Pharmaceutical Fine Chemicals S.r.l's score of 37 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teva Pharmaceutical Fine Chemicals S.r.l, headquartered in Italy, currently does not have available carbon emissions data for recent years. As such, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Teva Pharmaceutical Fine Chemicals S.r.l has not publicly disclosed any specific reduction targets or commitments related to climate action. This lack of information may reflect a broader industry context where many pharmaceutical companies are increasingly focusing on sustainability and carbon reduction initiatives. For stakeholders and environmentally conscious consumers, the absence of clear climate commitments may raise questions about the company's approach to environmental responsibility. As the industry evolves, it is anticipated that Teva Pharmaceutical Fine Chemicals S.r.l will align with global trends towards transparency and accountability in carbon emissions management.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teva Pharmaceutical Fine Chemicals S.r.l is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.